Baxter: Tests show suspect heparin was pure

Baxter International has determined that quality issues weren't involved in the deaths of two patients who took the company's heparin products. An array of forensic and analytical tests verify the heparin products were pure and didn't contain any contaminants, Baxter said. Report

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.